Literature DB >> 24385507

Mendelian disorders of high-density lipoprotein metabolism.

Federico Oldoni1, Richard J Sinke, Jan Albert Kuivenhoven.   

Abstract

High-density lipoproteins (HDLs) are a highly heterogeneous and dynamic group of the smallest and densest lipoproteins present in the circulation. This review provides the current molecular insight into HDL metabolism led by articles describing mutations in genes that have a large affect on HDL cholesterol levels through their roles in HDL and triglyceride metabolism. Using this information from both human and animal studies, it is discussed how HDL is produced, remodeled in the circulation, affected by factors that control the metabolism of triglyceride-rich lipoproteins, how it helps maintain cellular cholesterol homeostasis, and, finally, how it is catabolized. It can be concluded that HDL cholesterol as a trait is genetically heterogeneous, with as many as 40 genes involved. In most cases, only heterozygotes of gene variants are known, and HDL cholesterol as a trait is inherited in an autosomal-dominant manner. Only 3 Mendelian disorders of HDL metabolism are currently known, which are inherited in an autosomal-recessive mode.

Entities:  

Keywords:  cholesterol; lipoproteins, high-density lipoprotein

Mesh:

Substances:

Year:  2014        PMID: 24385507     DOI: 10.1161/CIRCRESAHA.113.300634

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  12 in total

Review 1.  HDL-targeted therapies: progress, failures and future.

Authors:  Bronwyn A Kingwell; M John Chapman; Anatol Kontush; Norman E Miller
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

2.  Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.

Authors:  Monica Gomaraschi; Alice Ossoli; Samuela Castelnuovo; Sara Simonelli; Chiara Pavanello; Gloria Balzarotti; Marcello Arca; Alessia Di Costanzo; Tiziana Sampietro; Gaetano Vaudo; Damiano Baldassarre; Fabrizio Veglia; Guido Franceschini; Laura Calabresi
Journal:  J Lipid Res       Date:  2017-03-28       Impact factor: 5.922

Review 3.  Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Authors:  Richard Kones; Umme Rumana
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

4.  Large HDL2 combined with inflammatory factors as superior predictors for coronary artery disease than small HDL3.

Authors:  Xiaoying Wu; Zhijian He; Runlu Sun; Xiangkun Xie; Qingqun Chen; Junjie Wang; Jinlan Bao; Jingjing Huang; Yuan Jiang; Yuling Zhang; Jingfeng Wang
Journal:  Ann Transl Med       Date:  2021-04

Review 5.  Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview.

Authors:  Lotte Smolders; Jogchum Plat; Ronald P Mensink
Journal:  J Nutr Metab       Date:  2017-06-12

6.  CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels.

Authors:  Chan Joo Lee; Mun Su Park; Miso Kim; Soo-Jin Ann; Jaeho Lee; Sungha Park; Seok-Min Kang; Yangsoo Jang; Ji Hyun Lee; Sang-Hak Lee
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

7.  Impact of Cholesterol on Ischemic Stroke in Different Human-Like Hamster Models: A New Animal Model for Ischemic Stroke Study.

Authors:  Lili Wei; Haozhe Shi; Xiao Lin; Xin Zhang; Yuhui Wang; George Liu; Xunde Xian
Journal:  Cells       Date:  2019-09-04       Impact factor: 6.600

Review 8.  High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk.

Authors:  Anouar Hafiane; Jacques Genest
Journal:  BBA Clin       Date:  2015-01-31

9.  The acute effects on duodenal gene expression in healthy men following consumption of a low-fat meal enriched with theobromine or fat.

Authors:  Lotte Smolders; Ronald P Mensink; Mark V Boekschoten; Rogier J J de Ridder; Jogchum Plat
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

Review 10.  High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.

Authors:  Maria Pia Adorni; Nicoletta Ronda; Franco Bernini; Francesca Zimetti
Journal:  Cells       Date:  2021-03-05       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.